circadian rhythm raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2025-10-17. Anything still debated is marked as such rather than presented as settled.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
Quality control for research materials includes identity confirmation by nuclear magnetic resonance and purity assessment by high-performance liquid chromatography. Mass spectrometry provides molecular weight confirmation and can detect related impurities. Purchasers should request a certificate of analysis that lists lot-specific data. Online products advertised for human use often lack such documentation. Distinguishing legitimate research material from mislabeled or contaminated samples is a recurring challenge in independent testing, and independent laboratories may use orthogonal methods to verify identity.
Detection of SR9009 in biological samples usually relies on liquid chromatography coupled to tandem mass spectrometry. This approach separates the compound from matrix components and identifies it by mass transitions. Because SR9009 can undergo metabolism, laboratories often look for both parent drug and specific metabolites. Sample preparation may involve protein precipitation or solid-phase extraction. Method validation examines sensitivity, carryover, and interference from related substances, and reference standards are required for accurate calibration.
| Property | Value | Notes |
|---|---|---|
| Common name | SR9009 | Also referred to as Stenabolic in non-scientific contexts. |
| Chemical class | Synthetic small molecule | Not a steroid or peptide hormone. |
| Receptor target | REV-ERBα and REV-ERBβ | Nuclear receptor agonist in preclinical studies. |
| Development status | Investigational | No approved human therapeutic indication. |
| Regulatory attention | Prohibited in sport | Listed by anti-doping authorities. |
Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.
Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.
In laboratory settings, SR9009 is typically characterized by liquid chromatography–mass spectrometry (LC-MS) or high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These methods can confirm identity and estimate purity, but they require reference standards for accurate quantification. Because SR9009 is not a licensed pharmaceutical, no harmonized pharmacopeial monograph exists. Laboratories often validate in-house methods for matrices such as plasma, urine, or cell culture media. Sample preparation may involve protein precipitation or liquid-liquid extraction before analysis.
Physicochemical behavior influences handling. SR9009 is described as a solid with limited aqueous solubility, so organic solvents such as dimethyl sulfoxide or ethanol are common in research stock solutions. Aqueous dilution can produce precipitates if the organic content is too low. Light, heat, and repeated freeze-thaw cycles may affect stability. Storage recommendations usually specify a desiccated freezer environment protected from light, but exact stability data depend on the formulation and matrix.
Research interest in SR9009 grew from studies showing improved running endurance in mice after short treatment periods. Those experiments linked the compound to increased mitochondrial content and fatty acid oxidation in muscle, but the findings come from animal models and specific dosing schedules. Independent replication has been limited, and the pathways connecting REV-ERB activation to exercise performance are still being mapped. Whether similar responses occur in humans is an open question.
SR9009 is often grouped with compounds studied for circadian and metabolic regulation rather than with classical anabolic steroids. Its interactions with nuclear receptors differ from those of androgen receptor ligands, and its proposed mechanisms involve transcriptional control rather than direct hormone signaling. Some sources classify it as a metabolic modulator because of observed effects on energy utilization. The distinction matters for regulation and for interpreting research results across different compound classes.
SR9009 is a synthetic small molecule developed as a REV-ERB agonist. It binds to REV-ERBα and REV-ERBβ, nuclear receptors that help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, the compound alters lipid and glucose handling and influences skeletal muscle oxidative capacity. Its exact effects in humans remain largely uncharacterized because controlled clinical trials have not been reported. The molecule is frequently described in preclinical literature as a metabolic modulator.
In the deep sea, the COMARGE project has studied the biodiversity patterns along and across the Chilean margin through a complexity of ecosystems such as methane seeps and oxygen minimum zones, reporting that such habitat heterogeneity may influence the biodiversity patterns of the local fauna. Seep fauna include bivalves of families Lucinidae, Thyasiridae, Solemyidae (Acharax sp.), and Vesicomyidae (Calyptogena gallardoi) and polychaetes (Lamellibrachia sp. and two other polychaete species). Furthermore, in these soft reduced sediments below the oxygen minimum zone off the Chilean margin, a diverse microbial community composed by a variety of large prokaryotes (mainly large multi-cellular filamentous "mega bacteria" of the genera Thioploca and Beggiatoa, and of "macrobacteria" including a diversity of phenotypes), protists (ciliates, flagellates, and foraminifers), as well as small metazoans (mostly nematodes and polychaetes) has been found. Gallardo et al. (2007) argue that the likely chemolithotrophic metabolism of most of these mega- and macrobacteria offer an alternative explanation to fossil findings, in particular to those from obvious non-littoral origins, suggesting that traditional hypotheses on the cyanobacterial origin of some fossils may have to be revised. Cold seeps (pockmarks) are also known from depths of 130 m in the Hecate Strait, British Columbia, Canada.
=== Controversy === Based on the statistics presented in earlier discussions, there is controversy with regard to a perceived lack of diversity within the donor sperm pool of many sperm banks. This includes, but is not limited to, height requirements implemented by some sperm banks. As a result, it is alleged that potential sperm recipients often encounter very limited sperm donor pool options. Lack of diversity results in very limited choices especially among ethnic minorities within the United States. Whenever an individual chooses to specify their preferred donor background, the number of available options (sperm donors that meet the particular individual's criteria) can dwindle down to the low single digits. Scott Brown from California Cryobank admitted: "We don't get as many minority applicants as we [would] like." Even after numerous attempts to reach out to numerous ethnic communities, the response can be nearly nonexistent. At the California Cryoback, Brown mentions that one out of 100 would be able to become final sperm donor while Ottey from the Fairfax Cryobank mentions one out of 200 would be able to become ultimate sperm donors. In addition, locations of the California Cryobank are in Los Angeles, Los Altos, California; mid-Manhattan, and Cambridge Massachusetts. These locations are known to have a population with higher socioeconomic latitude and being more likely to afford the services.
===== MeSH D08.811.399.403 – dna topoisomerases ===== MeSH D08.811.399.403.483 – dna topoisomerases, type i MeSH D08.811.399.403.483.249 – dna topoisomerases, type i, archaeal MeSH D08.811.399.403.483.300 – dna topoisomerases, type i, bacterial MeSH D08.811.399.403.483.500 – dna topoisomerases, type i, eukaryotic MeSH D08.811.399.403.741 – dna topoisomerases, type ii MeSH D08.811.399.403.741.249 – dna topoisomerases, type ii, archaeal MeSH D08.811.399.403.741.300 – dna topoisomerases, type ii, bacterial MeSH D08.811.399.403.741.300.500 – dna gyrase MeSH D08.811.399.403.741.300.750 – dna topoisomerase iv MeSH D08.811.399.403.741.500 – dna topoisomerases, type ii, eukaryotic
=== Ali El Mansour === Ali El Mansour (Fady Elsayed) is a new trader Adler hired due to his family ties to the Egyptian sovereign wealth fund. To rescue Pierpoint from a fatal debt crisis, Eric reaches out to Ali to have him bring in his family as the firm's buyers. Pierpoint is thereby absorbed into Al-Mi'raj, a holding company for the Egyptian sovereign wealth, who decide to consolidate the firm's trading to the New York headquarters and thereby shut down the London office.
Baby bottle nipples (also called teats) are typically made from either silicone or latex rubber. When used for nipples, silicone is clear, durable, and slightly harder than latex. Natural rubber latex teats are elastic, tear resistant, and may feel softer. Latex can absorb odors, while silicone does not. Latex can break down if exposed to sunlight. Some people have allergies to latex.
Sources: en.wikipedia.org
Promote their own products as healthy and unique, by clearly distinguishing their health claims from similar products, and by specifying naturally healthy ingredients. Consider extensions of existing brand lines. For example, Nestle extended their Boost product line by adding Kids Essentials to the line, thereby extending the adult-focused Boost line to a new market (children). Larger companies compete for market share by acquiring smaller companies that may own a particular market sector. For example, Coca-Cola purchased Glaceau from Energy Brands, and Odwalla, and Fuze Beverage from their respective founders, in order to increase Coca-Cola's market share. Explore new functional brands by identifying new markets and demands. Market segments of the functional beverage industry are divided mainly into four parts. Those include hydration, energy and rejuvenation, health and wellness, and weight management. Each segment has its own target market and consumers. Overlapping of target consumers does occur—not because of undefined market needs, but due to consumer acceptance of functional beverages.
The reinforced labour faction of the party initially accorded a more left-wing orientation and facilitated the cooperation with the social democrats. Typically, the Zentrum defended anti-capitalist policies and promoted social policy, but never agreed with social democrats on the right to private property. By the late Twenties, however, the Center Party gradually returned to more conservative policies.
=== Disease === Chronic Granulomatous Disease is an inherited disease of human neutrophils, wherein NOX2 is defective. Phagocytosis may still occur, but without proper functioning NOX2, there is no superoxide production, and therefore no respiratory burst. The bacterial infection is not cleared.
Peyote cacti were studied scientifically in the 1800s, culminating in the isolation of mescaline as the active psychedelic constituent in cacti, legal recognition of religious use, and ongoing exploration of the therapeutic potential of mescaline and other analogues. Mescaline was the first psychedelic compound to be characterized by the Western world and has been referred to as the "first psychedelic". Mescaline and the cacti that produce it are largely illegal worldwide, though exceptions exist for religious, scientific, or ornamental use, and the compound has influenced many notable cultural figures, for instance Aldous Huxley and Alexander Shulgin among others. Very few studies of mescaline in people have been conducted since the early 1970s. However, the drug is now being studied in terms of its effects and for potential medical use once again as of the early 2020s.
== Peptide fragmentation == Peptides are protonated in positive-ion mode. The proton initially locates at the N-terminus or a basic residue side chain, but because of the internal solvation, it can move along the backbone breaking at different sites which result in different fragments. The fragmentation rules are well explained by some publications. Three different types of backbone bonds can be broken to form peptide fragments: alkyl carbonyl (CHR-CO), peptide amide bond (CO-NH), and amino alkyl bond (NH-CHR).
Sources: en.wikipedia.org
=== Carbon footprint === UPS reported Total CO2e emissions (Direct + Indirect) for the twelve months ending December 31, 2020, at 16,500 Kt (+1,546/+10% y-o-y). UPS aims to reach net zero emissions by 2050.
The entry of U.S. troops into the war caused an intense increase in its industrial and agricultural production. However, the departure of U.S. soldiers left little labor for its economy; the remaining U.S. labor force was insufficient to meet the demands of the countryside and industry. Mexico and the United States signed an agreement in 1942 to regulate the flow of Mexican migrants (braceros) to the United States and compensate for the lack of U.S. workers. The agreement resulted in the Bracero Program. It established that braceros could not be employed in military service, could not suffer acts of discrimination, could not be used to displace U.S. workers, and that their basic needs had to be assured. The Bracero Program remained in effect until 1964 and benefited neighboring countries, securing needed labor for the United States and reducing unemployment in Mexico.
=== Venom === Although these spiders are capable of hunting and killing some of the most venomous spiders in the world such as the redback spider, they are not dangerous to humans. According to researchers Greta Binford and Pamela Zobel-Thropp, the effects of P. phalangioides venom on humans and other mammals are negligible. In humans, the P. phalangioides bite simply results in a mild stinging sensation that has no long-term health consequences.
==== United States ==== In April 2020, The Hill reported that markets selling live animals were still operating in the United States and that animal rights activists were calling for the closure of such markets, in addition to their existing calls to close factory farms. Fresh food markets were common in New York City until refrigeration became commonplace in the 20th century. From the 1990s to 2020, the number of live animal markets in New York City nearly doubled. As of 2020, there are more than 80 markets in New York City that stock live animals and slaughter them on-demand for customers. They are mostly poultry markets located in outer-borough immigrant communities where they are culturally significant and pose low public health risks relative to wildlife markets and other types of exotic markets.
=== Invention === In 1966 (1966) Sato Foods Industries Co., Ltd. invented alcohol pulverization. Sato is a food additives and seasoning manufacturer in Aichi Prefecture in Japan. (ja:佐藤食品工業 (愛知県)) A year later, in 1967, Sato began production and sales of various kinds of "high content alcohol powder Alcock" ("高含度アルコール粉末「アルコック」"). On 15 January 1974, a practical manufacturing process for alcohol powder was patented by Sato. Sato has patented the process in 17 countries around the world. In the 1970s Sato began promoting powdered alcohol in the United States. Test sales began in 1977 under the trade name "SureShot". The product "Palcohol" was announced for future release in the U.S. in 2015. In Turkey, on November 21, 1973, a former chemist named İsmail Serin invented a powdered version of rakı, a traditional Turkish anise-flavored alcoholic beverage.
Sources: en.wikipedia.org
It is a synthetic compound studied as an agonist of REV-ERB nuclear receptors. It is not an approved medicine and has mainly been examined in laboratory and animal research.
No. It is a small molecule that binds nuclear receptors involved in circadian regulation. Its classification differs from anabolic steroids or peptide hormones.
Published human clinical trial data are lacking. Most safety and activity information comes from preclinical models, so effects in people remain uncertain.
Liquid chromatography-tandem mass spectrometry is a common approach. It can detect the parent compound and its metabolites in biological matrices.